secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vir Biotechnology, Inc. (VIR)
CIK:        0001706431
Form:       8-K
Filed at:   2025-05-29T23:59:59+00:00
Accession:  0001628280-25-028356
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Vir Biotechnology stockholders elect directors, approve executive pay, ratify auditor at 2025 annual meeting
--------------------------------------------------------------------------------

- Jeffrey S. Hatfield and Saira Ramasastry elected as Class III directors each with >93 million votes for.
- Advisory vote on executive compensation approved: 100.5 million for, 4.3 million against.
- Ernst & Young LLP ratified as independent auditor for FY 2025 (116.3 million for).
- All three proposals passed; no material change in governance or operations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1706431/000162828025028356/0001628280-25-028356-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1706431/000162828025028356/vir-20250529.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-028356

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer